Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma

Antigen peptides and adjuvants have been extensively investigated for cancer immunotherapy, and they are expected to elicit specific immune responses for cancer treatment. However, the anti-cancer efficacy of antigen peptide and adjuvant-based cancer vaccines has been limited due to the inefficient...

Full description

Bibliographic Details
Main Authors: Li-Min Mu, Lei Liu, Rui Liu, Ya-Fei Du, Qian Luo, Jia-Rui Xu, Ying Xie, Wan-Liang Lu
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/9/2207